Indian Biotech Database

SUZHOU, China, May 31, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, announced... Read more ››

By: PR Newswire Association LLC. - 01 Jun 2020

Innovent Biologics Announced the Results of the Phase 1b Clinical Study of TYVYT(R) (Sintilimab Injection) in Combination with IBI305 (Bevacizumab Biosimilar) in the Treatment of Advanced Hepatocellular Carcinoma

SUZHOU, China, June 1, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, announced... Read more ››

By: PR Newswire Association LLC. - 01 Jun 2020

Sanofi announces closing of Regeneron stock sale

By: GlobenewsWire - 29 May 2020

Libtayo® (cemiplimab-rwlc) longer-term results in advanced cutaneous squamous cell carcinoma presented at ASCO 2020 show durable responses that deepen over time

By: GlobenewsWire - 29 May 2020

Sanofi names new leaders to Executive Committee

By: GlobenewsWire - 29 May 2020

Sanofi’s Board of Directors notes the resignation of Emmanuel Babeau and coopts Gilles Schnepp as Independent Director

By: GlobenewsWire - 28 May 2020

Sanofi announces pricing of Regeneron stock offering

By: GlobenewsWire - 27 May 2020

Sanofi: FDA approves Dupixent® (dupilumab) as first biologic medicine for children aged 6 to 11 years with moderate-to-severe atopic dermatitis

By: GlobenewsWire - 26 May 2020

Glenmark to Commence Another New Phase 3 Clinical Trial on a Combination of Two Anti-viral Drugs Favipiravir and Umifenovir in Hospitalized Patients of Moderate COVID-19 in India

MUMBAI, May 26, 2020 /PRNewswire/ -- Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has announced a new randomized, open-label study to test the combined efficacy of two antiviral drugs Favipiravir and Umifenovir as a potential COVID-19 treatment strategy.... Read more ››

By: PR Newswire Association LLC. - 26 May 2020

Related companies: Glenmark Pharmaceuticals Limited

Related companies: Institute of Natural Organic Agriculture (INORA)

Sanofi to highlight pipeline programs in a series of interactive virtual sessions leading to a R&D day event

By: GlobenewsWire - 18 May 2020

1 2 3 4 5 6 »

Looking for companies outside of India?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

June 2020
- Digital RESI – Three Day Conference
- BIO Digital
- Brussels: The Pharma Business Development Course

See Events »

Add an Event »

Latest company news

Novo Nordisk reports weight loss of 14.9% (16.9% if taken as intended) in STEP 1 trial
04 Jun 2020 (GlobenewsWire)

Novo Nordisk A/S – Share repurchase programme
03 Jun 2020 (GlobenewsWire)

Sanofi to launch “Action 2020”, a worldwide employee stock purchase plan
03 Jun 2020 (GlobenewsWire)

News in the Life Sciences Industry

Novo Nordisk reports weight loss of 14.9% (16.9% if taken as intended) in STEP 1 trial

Novo Nordisk A/S – Share repurchase programme

Sanofi to launch “Action 2020”, a worldwide employee stock purchase plan

European Commission approves Sarclisa® (isatuximab) for adults with relapsed and refractory multiple myeloma

Sarclisa® (isatuximab) combination therapy demonstrated superior progression free survival and clinically meaningful depth of response in patients with relapsed multiple myeloma

Sanofi to present oncology strategy, provide update on portfolio and emerging pipeline

Innovent Biologics Announced the Results of the Phase 1b Clinical Study of TYVYT® (Sintilimab Injection) in Combination with IBI305 (Bevacizumab Biosimilar) in the Treatment of Advanced Hepatocellular Carcinoma

Innovent Biologics Announced the Results of the Phase 1b Clinical Study of TYVYT(R) (Sintilimab Injection) in Combination with IBI305 (Bevacizumab Biosimilar) in the Treatment of Advanced Hepatocellular Carcinoma

Sanofi announces closing of Regeneron stock sale

Libtayo® (cemiplimab-rwlc) longer-term results in advanced cutaneous squamous cell carcinoma presented at ASCO 2020 show durable responses that deepen over time

Sanofi names new leaders to Executive Committee

Sanofi’s Board of Directors notes the resignation of Emmanuel Babeau and coopts Gilles Schnepp as Independent Director

Sanofi announces pricing of Regeneron stock offering

Sanofi: FDA approves Dupixent® (dupilumab) as first biologic medicine for children aged 6 to 11 years with moderate-to-severe atopic dermatitis

Glenmark to Commence Another New Phase 3 Clinical Trial on a Combination of Two Anti-viral Drugs Favipiravir and Umifenovir in Hospitalized Patients of Moderate COVID-19 in India

Novo Nordisk A/S – Share repurchase programme

Sanofi: information concerning the total number of voting rights and shares, April 2020

Sanofi intends to sell its equity investment in Regeneron; confirms no change to ongoing collaboration

Organic & Natural Health Association Hosts “The Nourish Mint” To Engage the Supply Chain

Sanofi to highlight pipeline programs in a series of interactive virtual sessions leading to a R&D day event

Looking for companies outside of India?

Partners

Upcoming Life Sciences Events

Latest company news